CRISPR Therapeutics AG (CRSP): Price and Financial Metrics
CRSP Price/Volume Stats
| Current price | $47.26 | 52-week high | $91.10 |
| Prev. close | $46.97 | 52-week low | $43.42 |
| Day low | $46.61 | Volume | 1,948,000 |
| Day high | $47.91 | Avg. volume | 1,485,359 |
| 50-day MA | $47.99 | Dividend yield | N/A |
| 200-day MA | $57.25 | Market Cap | 4.03B |
CRSP Stock Price Chart Interactive Chart >
CRISPR Therapeutics AG (CRSP) Company Bio
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.
CRSP Price Returns
| 1-mo | -1.62% |
| 3-mo | -2.94% |
| 6-mo | -14.45% |
| 1-year | -32.96% |
| 3-year | -41.36% |
| 5-year | -24.02% |
| YTD | -24.50% |
| 2023 | 54.00% |
| 2022 | -46.36% |
| 2021 | -50.51% |
| 2020 | 151.39% |
| 2019 | 113.18% |
Continue Researching CRSP
Here are a few links from around the web to help you further your research on CRISPR Therapeutics AG's stock as an investment opportunity:CRISPR Therapeutics AG (CRSP) Stock Price | Nasdaq
CRISPR Therapeutics AG (CRSP) Stock Quote, History and News - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...